Viewing StudyNCT02035072



Ignite Creation Date: 2024-05-06 @ 2:24 AM
Last Modification Date: 2024-10-26 @ 11:17 AM
Study NCT ID: NCT02035072
Status: COMPLETED
Last Update Posted: 2017-07-21
First Post: 2014-01-10

Brief Title: Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer
Sponsor: Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Organization: Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-11
Start Date Type: None
Primary Completion Date: 2016-12
Primary Completion Date Type: ACTUAL
Completion Date: 2016-12
Completion Date Type: ACTUAL
First Submit Date: 2014-01-10
First Submit QC Date: January 10 2014
Study First Post Date: 2014-01-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-07-19
Last Update Post Date: 2017-07-21
Last Update Post Date Type: ACTUAL